These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 8876669

  • 1. Comparative analyses of relative ERCC3 and ERCC6 mRNA levels in gliomas and adjacent non-neoplastic brain.
    Dabholkar MD, Berger MS, Vionnet JA, Overton L, Thompson C, Bostick-Bruton F, Yu JJ, Silber JR, Reed E.
    Mol Carcinog; 1996 Sep; 17(1):1-7. PubMed ID: 8876669
    [Abstract] [Full Text] [Related]

  • 2. Malignant and nonmalignant brain tissues differ in their messenger RNA expression patterns for ERCC1 and ERCC2.
    Dabholkar MD, Berger MS, Vionnet JA, Egwuagu C, Silber JR, Yu JJ, Reed E.
    Cancer Res; 1995 Mar 15; 55(6):1261-6. PubMed ID: 7882319
    [Abstract] [Full Text] [Related]

  • 3. Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis.
    Cheng L, Spitz MR, Hong WK, Wei Q.
    Carcinogenesis; 2000 Aug 15; 21(8):1527-30. PubMed ID: 10910954
    [Abstract] [Full Text] [Related]

  • 4. Genomic copy number changes of DNA repair genes ERCC1 and ERCC2 in human gliomas.
    Liang BC, Ross DA, Reed E.
    J Neurooncol; 1995 Oct 15; 26(1):17-23. PubMed ID: 8583241
    [Abstract] [Full Text] [Related]

  • 5. Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck.
    Cheng L, Sturgis EM, Eicher SA, Spitz MR, Wei Q.
    Cancer; 2002 Jan 15; 94(2):393-7. PubMed ID: 11900225
    [Abstract] [Full Text] [Related]

  • 6. Expression of oligodendrocytic mRNAs in glial tumors: changes associated with tumor grade and extent of neoplastic infiltration.
    Landry CF, Verity MA, Cherman L, Kashima T, Black K, Yates A, Campagnoni AT.
    Cancer Res; 1997 Sep 15; 57(18):4098-104. PubMed ID: 9307299
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY, Lakhter AJ, Loksh A, Yong WH, Riedinger MS, Miner JH, Sorokin LM, Ljubimov AV, Black KL.
    Cancer Res; 2001 Jul 15; 61(14):5601-10. PubMed ID: 11454714
    [Abstract] [Full Text] [Related]

  • 8. Evidence for in the appearance of mRNAs of nucleotide excision repair genes, in human ovarian cancer tissues.
    Reed E, Dabholkar M, Thornton K, Thompson C, Yu JJ, Bostick-Bruton F.
    Oncol Rep; 2000 Jul 15; 7(5):1123-8. PubMed ID: 10948350
    [Abstract] [Full Text] [Related]

  • 9. Analysis of DNA repair gene polymorphisms and survival in low-grade and anaplastic gliomas.
    Berntsson SG, Wibom C, Sjöström S, Henriksson R, Brännström T, Broholm H, Johansson C, Fleming SJ, McKinney PA, Bethke L, Houlston R, Smits A, Andersson U, Melin BS.
    J Neurooncol; 2011 Dec 15; 105(3):531-8. PubMed ID: 21643987
    [Abstract] [Full Text] [Related]

  • 10. Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents.
    Damia G, Imperatori L, Stefanini M, D'Incalci M.
    Int J Cancer; 1996 Jun 11; 66(6):779-83. PubMed ID: 8647649
    [Abstract] [Full Text] [Related]

  • 11. Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne's syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissues.
    Dabholkar M, Thornton K, Vionnet J, Bostick-Bruton F, Yu JJ, Reed E.
    Biochem Pharmacol; 2000 Dec 01; 60(11):1611-9. PubMed ID: 11077043
    [Abstract] [Full Text] [Related]

  • 12. Protein and mRNA levels of YKL-40 in high-grade glioma.
    Kazakova MH, Staneva DN, Koev IG, Staikov DG, Mateva N, Timonov PT, Miloshev GA, Sarafian VS.
    Folia Biol (Praha); 2014 Dec 01; 60(6):261-7. PubMed ID: 25629266
    [Abstract] [Full Text] [Related]

  • 13. Expression analyses of 27 DNA repair genes in astrocytoma by TaqMan low-density array.
    Jiang Z, Hu J, Li X, Jiang Y, Zhou W, Lu D.
    Neurosci Lett; 2006 Dec 01; 409(2):112-7. PubMed ID: 17034947
    [Abstract] [Full Text] [Related]

  • 14. KUB3 amplification and overexpression in human gliomas.
    Fischer U, Hemmer D, Heckel D, Michel A, Feiden W, Steudel WI, Hulsebos T, Meese E.
    Glia; 2001 Oct 01; 36(1):1-10. PubMed ID: 11571779
    [Abstract] [Full Text] [Related]

  • 15. Increased steady state mRNA levels of DNA-repair genes XRCC1, ERCC2 and ERCC3 in brain of patients with Down syndrome.
    Fang-Kircher SG, Labudova O, Kitzmueller E, Rink H, Cairns N, Lubec G.
    Life Sci; 1999 Oct 01; 64(18):1689-99. PubMed ID: 10328528
    [Abstract] [Full Text] [Related]

  • 16. Expression of multiple larger-sized transcripts for several genes in oligodendrogliomas: potential markers for glioma subtype.
    Xu X, Joh HD, Pin S, Schiller NI, Prange C, Burger PC, Schiller MR.
    Cancer Lett; 2001 Sep 28; 171(1):67-77. PubMed ID: 11485829
    [Abstract] [Full Text] [Related]

  • 17. Excision repair cross-complementing rodent repair deficiency gene 2 expression and chloroethylnitrosourea resistance in human glioma cell lines.
    Chen ZP, McQuillan A, Mohr G, Panasci LC.
    Neurosurgery; 1998 May 28; 42(5):1112-9. PubMed ID: 9588557
    [Abstract] [Full Text] [Related]

  • 18. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.
    Ferletta M, Uhrbom L, Olofsson T, Pontén F, Westermark B.
    Mol Cancer Res; 2007 Sep 28; 5(9):891-7. PubMed ID: 17855658
    [Abstract] [Full Text] [Related]

  • 19. Excision repair cross complementing 3 expression is involved in patient prognosis and tumor progression in esophageal cancer.
    Terashita Y, Ishiguro H, Haruki N, Sugiura H, Tanaka T, Kimura M, Shinoda N, Kuwabara Y, Fujii Y.
    Oncol Rep; 2004 Oct 28; 12(4):827-31. PubMed ID: 15375507
    [Abstract] [Full Text] [Related]

  • 20. Expression of ether à go-go potassium channels in human gliomas.
    Patt S, Preussat K, Beetz C, Kraft R, Schrey M, Kalff R, Schönherr K, Heinemann SH.
    Neurosci Lett; 2004 Sep 30; 368(3):249-53. PubMed ID: 15364405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.